Shop All Virus Production Media

CTS™ LV-MAX™ Production Medium

CTS LV-MAX Production Medium is a chemically-defined, serum-free, protein-free medium validated for recombinant lentiviral vector production. In addition to supporting high cell density suspension cultures of CTS Viral Production Cells (HEK293F-derived cells), this medium is suitable for preclinical-, clinical-, and commercial-scale transient transfection and lentiviral production when used with the CTS LV-MAX Transfection Kit. CTS LV-MAX Production Medium undergoes stringent QC testing to ensure it is appropriate for the manufacturing of cell and gene therapy applications.

CTS LV-MAX Production Medium may be applicable for other recombinant viral vector production that uses a HEK293 medium.

CTS LV-MAX Production Medium features include:
• Supports CTS Viral Production Cells to achieve densities of over 1 x 107 cells/mL with minimal cell clumping
• Enables high viral titers of up to 1 x 108 TU/mL (unconcentrated lentiviral vectors–GFP)
• Scalable protocol for 96-deep well blocks, flasks, and bioreactors
• Regulatory-compliant medium manufactured in conformity with cGMP for medical devices, 21 CFR, Part 820, and certified to the ISO 13485. Drug Master File and Regulatory Support File available upon request.

CTS LV-MAX Production Medium is formulated with GlutaMAX-I reagent. It is ready to use, with no supplementation required. The chemically defined formulation results in high reproducibility and lot-to-lot reliability. The medium contains no human or animal-origin components. It is not recommended for adherent cell cultures. The formulation of this product is identical to research-grade LV-MAX Production Medium, but CTS LV-MAX Production Medium is validated for clinical and commercial therapeutic applications.

Custom configuration and packaging available upon request.

CD BHK-21 Production Medium (Gibco™)

Gibco® CD BHK-21 Production Medium is a chemically defined, protein-free cell culture medium. It is designed to support the growth of BHK-21 cells in serum-free suspension culture. This medium is suitable for large-scale manufacturing applications.

CD BHK-21 Production Medium is manufactured as follows:
WithWithout
• L-glutamine• Phenol Red
• Dry powder formatProtein hydrolysates

Gibco® CD BHK-21 Production Medium is the first cell culture medium supporting complete serum-free and protein-free processes for BHK-21 cells. The dry powder format is easy to reconstitute, since it has no hydrolysates in the formulation. Adapting cells from serum-containing media is a rapid and simple procedure. BHK-21 cells can achieve high cell densities and maintain high cell viability in this medium.

Gibco® CD BHK-21 Production Medium is suitable for large-scale suspension culture. Because it does not require supplementation with serum or other undefined components, Gibco® CD BHK-21 Production Medium eliminates the risks associated with serum, while allowing you to achieve consistent virus titers and simplifying downstream purification.

cGMP Manufacturing
Gibco® CD BHK-21 Production Medium is manufactured at a cGMP-compliant facility located in Grand Island, New York. The facility is registered with the FDA as a medical device manufacturer and is certified to ISO 13485 standards.

VP-SFM AGT™ Medium (Gibco™)

VP-SFM AGT™ is a serum-free, ultra-low protein medium in an easy-to-use granular format. It is designed for the growth of VERO cells for virus production and for the growth of COS-7, MDCK, BHK-21 and Hep-2 cells for recombinant protein production.
Advanced Granulation Technology = AGT

Adenovirus Expression Medium (AEM), for PER.C6™ cells (Gibco™)

Adenovirus Expression Medium (AEM) is recommended for the growth of PER.C6® cells in suspension and for the production of viruses and viral vectors in these cells. It is an animal-origin free cell culture medium without components directly derived from human or animal sources. Each lot of AEM is performance tested for cell growth with PER.C6® cells and AEM has been qualified to produce adenovirus and influenza viruses. It also supports HEK 293 cell growth. Glutamine or GlutaMAX™-I supplementation is required.

OptiPRO™ SFM (Gibco™)

OptiPRO™ SFM is a serum-free, animal origin-free culture medium designed for growth of several kidney-derived cell lines including MDBK, MDCK, PK-15 and VERO for virus or recombinant protein production. In addition, OptiPRO™ SFM has successfully grown other cell lines, such as Hela, BHK-21 and COS-7. Gibco® OptiPRO™ SFM features:
• Serum-free, animal origin-free, low protein formulation
• Direct adaptation for many popular cell lines

Serum-free, animal origin-free, low protein formulation
Gibco® OptiPRO™ SFM is formulated with a very low protein concentration (< 10 µg/ml), allowing for easier purification of your recombinant protein.

Direct adaptation for many popular cell lines
Gibco® OptiPRO™ SFM has been designed for growth of kidney-derived cell lines such as MDCK, MDBK, VERO and PK-15. In addition, OptiPRO™ SFM has successfully grown other cell lines, such as Hela, BHK-21 and COS-7, allowing you to choose a single medium for multiple cell lines.

Product Use
For Research Use Only. Not for use in diagnostic procedures.

cGMP Manufacturing and Quality System
Gibco® OptiPRO™ SFM is manufactured at a cGMP compliant facility located in Grand Island, New York. The facility is registered with the FDA as a medical device manufacturer and is certified to ISO 13485 standards.

VP-SFM (1X) (Gibco™)

VP-SFM is a serum-free, ultra-low protein (5 µg/ml) medium containing no proteins, peptides, or other components of animal or human origin. It is designed for the growth of VERO cells for virus production (1). This medium is suitable for the growth of COS-7, MDCK, BHK-21 (suspension culture) and HEp2 cells, and for recombinant protein production.

Formulated without L-glutamine for increased stability; add 20 ml of 200 mM L-glutamine or 20 ml of GlutaMAX™-I supplement per 1,000 ml of medium prior to use.

VP-SFM AGT™ Medium (Gibco™)

VP-SFM AGT™ is a serum-free, ultra-low protein medium in an easy-to-use granular format. It is designed for the growth of VERO cells for virus production and for the growth of COS-7, MDCK, BHK-21 and Hep-2 cells for recombinant protein production.
Advanced Granulation Technology = AGT

LV-MAX™ Production Medium (Gibco™)

Gibco LV-MAX Production Medium is a chemically defined, serum-free, protein-free medium, specially developed for high-density growth and transfection of Gibco Viral Production Cells (suspension-adapted HEK 293-derived cells) promoting high-titer lentiviral production.

• Supports growth of suspension Viral Production Cells to densities of over 1.0 x 107 cells/mL
• Enables sustained, high-level production of high-density transiently transfected cultures, achieving titer of up to 1 x 108 TU/mL (unconcentrated LVVs-GFP)
• Supports growth and transfection of Viral Production Cells in culture formats from 96-deep well blocks to 2-L flasks and bioreactors

LV-MAC Production Medium is ready to use, with no supplementation required. The chemically defined formulation results in high reproducibility and lot-to-lot reliability. The medium is not recommended for adherent cell cultures.

CD BHK-21 Production Medium (Gibco™)

Gibco® CD BHK-21 Production Medium is a chemically defined, protein-free cell culture medium. It is designed to support the growth of BHK-21 cells in serum-free suspension culture. This medium is suitable for large-scale manufacturing applications.

CD BHK-21 Production Medium is manufactured as follows:
WithWithout
• L-glutamine• Phenol Red
• Dry powder formatProtein hydrolysates

Gibco® CD BHK-21 Production Medium is the first cell culture medium supporting complete serum-free and protein-free processes for BHK-21 cells. The dry powder format is easy to reconstitute, since it has no hydrolysates in the formulation. Adapting cells from serum-containing media is a rapid and simple procedure. BHK-21 cells can achieve high cell densities and maintain high cell viability in this medium.

Gibco® CD BHK-21 Production Medium is suitable for large-scale suspension culture. Because it does not require supplementation with serum or other undefined components, Gibco® CD BHK-21 Production Medium eliminates the risks associated with serum, while allowing you to achieve consistent virus titers and simplifying downstream purification.

cGMP Manufacturing
Gibco® CD BHK-21 Production Medium is manufactured at a cGMP-compliant facility located in Grand Island, New York. The facility is registered with the FDA as a medical device manufacturer and is certified to ISO 13485 standards.